Case Study: Global Biopharmaceutical Company boosts HCP engagement and achieves 60% email open rates with Veeva Systems' CRM Approved Email

Global Biopharmaceutical Company Engages HCPs More Effectively with Compliant Email

A global biopharmaceutical company preparing two blockbuster drug launches needed a way to extend education and engagement with healthcare professionals beyond face-to-face visits while ensuring all communications remained medically, legally, and regulatorily approved. The challenge was to give field teams the ability to send personalized email content that was both effective and fully compliant, using a solution built for life sciences.

The company deployed Veeva CRM Approved Email, letting reps and MSLs send only MLR‑approved content directly from Veeva CRM. More than 300 users across the US, 10 European markets, and Australia gained the capability, yielding 60% open rates (about three times the industry average), a 30% increase in customer interactions, rapid template updates within 24 hours, and streamlined content management, analytics, and cross‑team collaboration.